Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiushi Tang

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Genetics|September 12, 2022
Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signatureXueliang Zhou, Batuer Aikemu, Shuchun Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2008
Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive deliveryRejean Liqun Wang, Thomas McLaughlin, Travis Cossette, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2012
Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapyAllison M Keeler, Thomas Conlon, Glenn Walter, et al.
Cancer Letters|July 14, 2022
Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapyQiushi Tang, Shuo Yang, Guangpeng He, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
A Compact Base Editor Rescues AATD-associated Liver and Lung Disease in Mouse ModelsJenny Gao, Nathan Bamidele, Debora Pires-Ferreira, et al.
Molecular Therapy. Methods & Clinical Development|March 6, 2024
Biodistribution and safety of a single rAAV3B-AAT vector for silencing and replacement of alpha-1 antitrypsin in <i>Cynomolgus macaques</i>Meghan Blackwood, Alisha M Gruntman, Qiushi Tang, et al.
Human Gene Therapy|March 31, 2018
In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT DeficiencyChun-Qing Song, Dan Wang, Tingting Jiang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2017
Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin DeficiencyFlorie Borel, Qiushi Tang, Gwladys Gernoux, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 27, 2007
In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNAPedro E Cruz, Christian Mueller, Travis L Cossette, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 28, 2005
Localized gene expression following administration of adeno-associated viral vectors via pancreatic ductsScott A Loiler, Qiushi Tang, Tracy Clarke, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Genetics|September 12, 2022
Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signatureXueliang Zhou, Batuer Aikemu, Shuchun Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2008
Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive deliveryRejean Liqun Wang, Thomas McLaughlin, Travis Cossette, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2012
Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapyAllison M Keeler, Thomas Conlon, Glenn Walter, et al.
Cancer Letters|July 14, 2022
Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapyQiushi Tang, Shuo Yang, Guangpeng He, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
A Compact Base Editor Rescues AATD-associated Liver and Lung Disease in Mouse ModelsJenny Gao, Nathan Bamidele, Debora Pires-Ferreira, et al.
Molecular Therapy. Methods & Clinical Development|March 6, 2024
Biodistribution and safety of a single rAAV3B-AAT vector for silencing and replacement of alpha-1 antitrypsin in <i>Cynomolgus macaques</i>Meghan Blackwood, Alisha M Gruntman, Qiushi Tang, et al.
Human Gene Therapy|March 31, 2018
In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT DeficiencyChun-Qing Song, Dan Wang, Tingting Jiang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2017
Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin DeficiencyFlorie Borel, Qiushi Tang, Gwladys Gernoux, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 27, 2007
In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNAPedro E Cruz, Christian Mueller, Travis L Cossette, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 28, 2005
Localized gene expression following administration of adeno-associated viral vectors via pancreatic ductsScott A Loiler, Qiushi Tang, Tracy Clarke, et al.
Pageof 4